Claims for Patent: 7,912,651

Summary for Patent: 7,912,651

Title:	Function homology screening
Abstract:	A method of screening biologically active agent based on the analysis of complex biological responses in culture. Methods for selecting cells and culture conditions for such screens are provided, as well as the identification of an optimized set of discrete parameters to be measured, and the use of biomap analysis for rapid identification and characterization of drug candidates, genetic sequences acting pathways, and the like. A feature of the invention is simultaneous screening of a large number of cellular pathways, and the rapid identification of compounds that cause cellular responses.
Inventor(s):	Berg; Ellen L. (Palo Alto, CA), Butcher; Eugene C. (Portola Valley, CA), Melrose; Jennifer (La Honda, CA), Plavec; Ivan (Sunnyvale, CA)
Assignee:	BioSeek LLC (Burlingame, CA)
Application Number:	10/220,999
Patent Claims:	1. A method for identifying a mechanism of action on predetermined cellular signaling pathways for a biologically active agent on a mammalian cell in a cell culture, using at least two cell culture assay combinations, wherein a first cell culture assay combination of said at least two comprises at least two factors sufficient to activate two or more cell signaling pathways in said cell, in said cell culture, and a second cell culture assay combination of said at least two is a control cell culture identical to said first cell culture except for lacking said biologically active agent; and wherein said mechanism of action was previously unknown for said biologically active agent, said method comprising: contacting said first cell culture with said biologically active agent; incubating said cell cultures; and measuring, simultaneously or in sequence, at least three parameters normalized to be a ratio of test to control data on said second cell culture assay combination whose levels respond to up or down regulation of at least one of said pathways and normalizing to generate a biomap; wherein the mechanism of action in cellular pathways of said biologically active agent is identified by analyzing said biomap by a multiparameter pattern recognition algorithm to quantify relatedness of said biomap to reference biomaps that include predetermined agents that target specific pathways, wherein the presence or absence of relatedness to said reference biomaps provides a characterization of said agent mechanism of action; and wherein each of said three parameters is modulated by at least one component in one of the assay combinations used to generate the biomap of the biologically active agent or to generate the reference biomaps. 2. A method for characterization of a biologically active agent according to its mechanism of action, the method comprising: contacting said agent with cells in at least one cell culture assay combination comprising at least two factors acting on said cells; recording changes in at least three different cellular parameter readouts as a result of introduction of said agent; deriving a biomap from said changes in parameter readouts, wherein said biomap comprises data normalized to be a ratio of test to control data on the same cell type under control conditions in the absence of said biologically active agent, and said parameters are optimized so that the set of data in the biomap is sufficiently informative that it can discriminate the mechanism of action of said agent; analyzing said biomap by a multiparameter pattern recognition algorithm to quantify relatedness of said biomap to reference biomaps that include predetermined agents that target specific pathways, wherein the presence or absence of relatedness to said reference biomaps provides a characterization of said agent mechanism of action. 3. The method according to claim 2, wherein said analyzing step comprises: classifying said biomap for a single biologically active agent for relatedness to a plurality of biomaps in a database. 4. A method for characterization of a biologically active agent according to its mechanism of action, the method comprising: contacting said agent with human primary cells in at least one cell culture assay combination comprising at least two factors acting on said cells; recording changes in at least three different cellular parameter readouts as a result of introduction of said agent; deriving a biomap from said changes in parameter readouts, wherein said biomap comprises data normalized to be a ratio of test to control data on the same cell type under control conditions in the absence of said biologically active agent, and said parameters are optimized so that the set of data in the biomap is sufficiently informative that it can discriminate the mechanism of action of said agent; analyzing said biomap by a multiparameter pattern recognition algorithm to quantify relatedness of said biomap to reference biomaps that include predetermined agents that target specific pathways, wherein the presence or absence of relatedness to said reference biomaps provides a characterization of said agent mechanism of action. 5. The method according to claim 2, wherein said cells are endothelial cells. 6. The method according to claim 2, wherein said biologically active agent is an organic compound. 7. The method according to claim 2, wherein said cells are endothelial cells and said assay combination comprises at least two of TNF-.alpha., IL-.gamma., IL-4, IL-13, histamine and IL-1 activities; and said parameters comprise at least two of ICAM-1, VCAM-1, E-selectin, P-selectin, IL-8, MCP-1, Eotaxin, CD31, HLA-DR, IP-10, and MIG. 8. A screening system for determining a mechanism of action of a biologically active agent, said system comprising a panel comprising at least two cell culture assay combinations comprising cells and at least two factors affecting at least two pathways, wherein one of said at least two assay combinations comprises said biologically active agent; assay reagents for measuring at least three parameters associated with said pathways; and a data processor for analyzing the data from said biological culture in relation to at least one control agent of predetermined activity. 9. The system according to claim 8, wherein said data processor comprises a plurality of biomaps in a database, wherein said biomaps are prepared according to the method comprising: adding a biologically active agent to said test cell culture assay combination and to a control cell culture lacking at least one of said factors; measuring at least three parameters associated with said plurality of pathways in said test cell culture and in said control cell culture and normalizing to produce a biomap; wherein the mechanism of action of said biologically active agent is identified by analyzing said biomap by a multiparameter pattern recognition algorithm to quantify relatedness of said biomap to reference biomaps that include predetermined agents that target specific pathways, wherein the presence or absence of relatedness to said reference biomaps provides a characterization of said agent mechanism of action. 10. The method according to claim 1, wherein the mechanism of action of said biologically active agent is identified by comparing said biomap with a plurality of biomaps generated from agents having predetermined mechanisms of action. 11. A method for determining the mechanism of action of a biologically active agent according to its effect on cellular signaling pathways, the method comprising: contacting a candidate biologically active agent with a cell culture assay combination, wherein said cell culture assay combination comprises human cells in an activated state as a result of adding to said culture at least three factors in an amount and for a time sufficient to induce said activated state; recording changes in at least three different cellular parameter readouts after introduction of said agent; deriving a biomap dataset from said changes in parameter readouts wherein said biomap comprises data normalized to control data on the same cell type under control conditions comprising said at least three factors and lacking said biologically active agent, and wherein output parameters are optimized so that the biomap dataset is sufficiently informative that it can discriminate the mechanism of action of an agent; analyzing said biomap by a multiparameter pattern recognition algorithm to quantify relatedness of said biomap to reference biomaps that include predetermined agents that target specific pathways, wherein the presence or absence of relatedness to said reference biomaps provides a characterization of said agent mechanism of action. 12. The method according to claim 2, wherein said cells are endothelial cells and said assay combination comprises IL-4 and histamine activities; and said parameters comprise at least two of VCAM-1, P-selectin, and Eotaxin.

Details for Patent 7,912,651

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Jubilant Hollisterstier Llc	N/A	positive skin test control-histamine	Injection	103891	03/13/1924		2040-01-28